A three-year longitudinal evaluation of the forearm bone density of users of etonogestrel- and levonorgestrel-releasing contraceptive implants
- PMID: 17997844
- PMCID: PMC2200638
- DOI: 10.1186/1742-4755-4-11
A three-year longitudinal evaluation of the forearm bone density of users of etonogestrel- and levonorgestrel-releasing contraceptive implants
Abstract
Background: The aim of this study was to evaluate bone mineral density (BMD) at baseline and at 18 and 36 months of use of etonogestrel (ENG)-and levonorgestrel (LNG)-releasing contraceptive implants. This is a continuation of a previous study in which BMD was evaluated at baseline and at 18 months of use.
Methods: A total of 111 women, 19-43 years of age, were randomly allocated to use one of the two implants. At 36 months of follow-up, only 36 and 39 women were still using the ENG- and LNG-releasing implants, respectively. BMD was evaluated at the distal and at the ultra-distal radius of the non-dominant forearm using dual-energy X-ray absorptiometry.
Results: There was no difference in the BMD of users of either implant at 18 and at 36 months. BMD was significantly lower at 18 and at 36 months at the distal radius in both groups of users compared to pre-insertion values; however, no difference was found at the ultra-distal radius.
Conclusion: Women 19-43 years of age using either one of these two contraceptive implants for 36 months had lower BMD values at the distal radius compared to pre-insertion values; however, no difference was found at the ultra-distal radius.
Similar articles
-
A prospective study of the forearm bone density of users of etonorgestrel- and levonorgestrel-releasing contraceptive implants.Hum Reprod. 2006 Feb;21(2):466-70. doi: 10.1093/humrep/dei358. Epub 2005 Oct 27. Hum Reprod. 2006. PMID: 16253974 Clinical Trial.
-
Prospective study of the forearm bone mineral density of long-term users of the levonorgestrel-releasing intrauterine system.Hum Reprod. 2010 May;25(5):1158-64. doi: 10.1093/humrep/deq043. Epub 2010 Feb 25. Hum Reprod. 2010. PMID: 20185512
-
Effects of levonorgestrel-releasing subdermal contraceptive implants on bone density and bone metabolism.Contraception. 1999 Sep;60(3):161-6. doi: 10.1016/s0010-7824(99)00080-3. Contraception. 1999. PMID: 10640160 Clinical Trial.
-
An evaluation of the levonorgestrel-releasing IUD: its advantages and disadvantages when compared to the copper-releasing IUDs.Contraception. 1991 Dec;44(6):573-88. doi: 10.1016/0010-7824(91)90078-t. Contraception. 1991. PMID: 1773615 Review.
-
Risks and benefits, advantages and disadvantages of levonorgestrel-releasing contraceptive implants.Drug Saf. 2003;26(5):303-35. doi: 10.2165/00002018-200326050-00002. Drug Saf. 2003. PMID: 12650633 Review.
Cited by
-
U.S. Medical Eligibility Criteria for Contraceptive Use, 2024.MMWR Recomm Rep. 2024 Aug 8;73(4):1-126. doi: 10.15585/mmwr.rr7304a1. MMWR Recomm Rep. 2024. PMID: 39106314 Free PMC article.
-
Examining the efficacy, safety, and patient acceptability of the etonogestrel implantable contraceptive.Patient Prefer Adherence. 2009 Nov 3;3:205-11. doi: 10.2147/ppa.s4299. Patient Prefer Adherence. 2009. PMID: 19936163 Free PMC article.
-
Steroidal contraceptives: effect on bone fractures in women.Cochrane Database Syst Rev. 2014 Jun 24;2014(6):CD006033. doi: 10.1002/14651858.CD006033.pub5. Cochrane Database Syst Rev. 2014. PMID: 24960023 Free PMC article.
-
Osteoporosis in a young woman after 6 years of levonorgestrel administration from intrauterine devices?BMJ Case Rep. 2009;2009:bcr07.2008.0484. doi: 10.1136/bcr.07.2008.0484. Epub 2009 Mar 5. BMJ Case Rep. 2009. PMID: 21686786 Free PMC article.
-
Contraceptive Care in the Rheumatic Diseases: A Review.J Clin Rheumatol. 2024 Oct 1;30(7S Suppl 1):S5-S12. doi: 10.1097/RHU.0000000000002124. J Clin Rheumatol. 2024. PMID: 39325120 Free PMC article. Review.
References
LinkOut - more resources
Full Text Sources